An independent FDA Pharmacy Compounding Advisory Committee voted to recommend that several peptides be considered for inclusion on the 503A Bulks List, potentially allowing qualifying compounding pharmacies to prepare them when prescribed by a licensed clinician
Clerk LH, Rattigan S, Clark MG
Research Applications BPC-157 has been widely investigated in laboratory settings exploring regenerative biology and tissue repair mechanisms
For injections into the knee joint, there are four basic portals of entry: superolateral, superomedial, anterolateral, and anteromedial
Proper pharmacy licensing, prescription oversight, quality systems, and clinical monitoring can reduce some risks, but they do not replace the controlled trials and premarket review required for FDA approval of a specific drug product